"We have identified a novel vulnerability in NRAS-dependent melanoma and developed a combination therapy that may offer a valuable strategy to target therapy resistant melanoma," she added. Because NRAS and the other members of the RAS family have proven to be difficult to target directly, the ...
from Google Alert - vulnerability https://ift.tt/2HvOAj4
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment